Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation
- 8 November 2011
- Vol. 29 (48) , 9064-9074
- https://doi.org/10.1016/j.vaccine.2011.09.057
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01Science, 2010
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Science, 2010
- Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody RecognitionJournal of Biological Chemistry, 2010
- The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120Vaccine, 2009
- Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitopeVirology, 2009
- Fc receptor-mediated antiviral antibodiesCurrent Opinion in HIV and AIDS, 2009
- Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza virusesVaccine, 2008
- In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120Virology, 2008
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007
- Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsVaccine, 2006